This Is Your Brain: A lecture and Q&A with UNC neurologist Dan Kaufer, MD, will take place at 6:30 p.m. Wednesday, March 15, at the UNC Fed Ex Global Education Center, 301 Pittsboro St., Chapel Hill.
UNC Lineberger researchers led by Dr. Timothy R. Gershon report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma.
From non-invasive brain stimulation to the inner workings of fMRI, UNC researchers will study the human brain like never before to address neurological and psychiatric conditions such as depression, Alzheimer’s, and schizophrenia.
Each Thursday evening in October, a member of the UNC School of Medicine faculty will share their insights on the brain from a scientific, medical, and philosophical perspective.
Collaboration between the UNC School of Medicine and the University of Minnesota aims to provide scientists with breakthrough information about how the human brain develops from birth through early childhood.
UNC's James Howard, MD, was the principal investigator of the study.
UNC Hospitals receives Get With The Guidelines-Stroke Gold Plus Quality Achievement Award with Target: Stroke Honor Roll Elite
American Heart Association recognizes UNC Hospitals' commitment to quality stroke care
Effective May 30, 2015, the UNC Neurology Clinic converted to a hospital-based clinic.
In a double-blinded, randomized study, UNC researchers found that the IQ scores of people who underwent tDCS brain stimulation improved markedly less than did the IQ scores of people in the placebo group.
Using a weak electric current to alter a specific brain activity pattern, UNC School of Medicine researchers increased creativity in healthy adults. Now they’re testing the same experimental protocol to alleviate symptoms in people with depression.
In February, UNC neurologist Hae Won Shin, MD, and neurosurgeon Eldad Hadar, MD, were the first in the state to implant the NeuroPace RNS System following the medical device’s recent FDA approval. In clinical trials, the NeuroPace system greatly reduced the number of seizures experienced by patients with severe epilepsy.
The nonprofit organization Alzheimer’s North Carolina, Inc., has awarded a $130,000 grant to launch a new collaborative effort by the UNC School of Medicine, Duke University and other academic research institutions to join forces in the race to prevent and cure Alzheimer’s disease.
The invitation for Kevin Guskiewiz came after a series of expert interviews with the White House Office of Science and Technology, where he was asked his thoughts about new directions for concussion research.
When Tammie Parris suffered a brain aneurysm, life as she knew it changed. Her response was to work tirelessly to change the lives of others by raising awareness about aneurysms.
UNC’s William Powers, MD, provides the first hard evidence for how to treat stroke patients with poor collateral blood vessel formation.
The research of William Powers, MD, has illuminated our understanding of stroke and guided better treatment for patients throughout three decades, a feat which earned him a Feinberg Award from the American Stroke Association.
American Stroke Association honors outstanding contributors to stroke research
Former pro football players to receive medical evaluations through UNC’s Brain & Body Health Program.
C.J. Malanga discovered that three specific drugs affect three different kinds of neurotransmitter receptors that all seem to play roles in Fragile X Syndrome.
The UNC Neurodiagnostics and Sleep Science (NDSS) Program recognized its first class of graduates at a celebration on Friday, May 17, on the UNC Chapel Hill campus.